Banjo Health vs Cohere Health (2026)
Two payer side prior authorization platforms, splitting on benefit type and on breadth. Banjo is pharmacy benefit weighted, reading prescriber notes directly and producing an inspectable structured recommendation with the evidence attached rather than a score, backed by HITRUST at the risk based tier. Cohere is the broader clinical intelligence platform, covering utilization management, payment integrity, appeals, care management and policy management for health plans, which suits an organisation that wants one consistent model of medical necessity across all of them. The question neither answers, and the one that should decide this, is what proportion of AI recommended denials are overturned on appeal. A platform that is fast and wrong costs more than the staff it replaced, and in this workflow the cost lands on a patient waiting for treatment rather than on the plan.
- It is weighted toward pharmacy benefit rather than medical, which is a genuinely different determination workflow, and it reads prescriber notes directly rather than working from a submitted form alone.
- Its central output is an inspectable structure rather than an opaque score, and every recommendation carries detailed evidence, which is the correct design when the output can result in a denial.
- HITRUST at the risk based two year tier, which incorporates the privacy requirements and is the more demanding assessment rather than the lighter entry level one.
- The platform reaches beyond authorisation into payment integrity, appeals, care management and policy management, so one vendor covers the utilization management estate rather than one decision point.
- The clinical intelligence framing is broader and the customer base larger, which matters when a plan wants a single model of medical necessity applied consistently across functions.
- Accreditation matters here in a way it does not elsewhere, and the stronger accredited posture transfers benefit to the plan rather than leaving it exposed.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Banjo Health and Cohere Health are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Banjo Health | Cohere Health |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Headquarters | Washington, District of Columbia | Boston, Massachusetts |
| Website | banjohealth.com | coherehealth.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards Banjo Health its top capability grade on AI Centrality and Setting and Specialty Coverage. Set against Cohere Health, Banjo Health grades higher on Model and Technology Transparency and AI Liability and Recourse. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index awards Cohere Health its top capability grade on several axes, including AI Centrality, Autonomy and Oversight Model and Clinical and Operational Evidence. Set against Banjo Health, Cohere Health grades higher on several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose Banjo Health or Cohere Health?
On the axes where the AI Health Index separates them, Banjo Health grades higher on Model and Technology Transparency and AI Liability and Recourse, and Cohere Health grades higher on several axes, including Autonomy and Oversight Model, Clinical and Operational Evidence and Security Certifications and Trust Center. Cohere Health leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do Banjo Health and Cohere Health differ most?
The widest separation the AI Health Index records between Banjo Health and Cohere Health is on Model and Technology Transparency, where Banjo Health grades B and Cohere Health grades C. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do Banjo Health and Cohere Health grade the same?
The AI Health Index grades Banjo Health and Cohere Health the same on several axes, including AI Centrality, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
Prior authorization is the workflow where an AI output most directly results in care being delayed or denied, and neither vendor publishes a bias evaluation or subgroup performance analysis. Washington's rule states that a carrier is not exempt from prior authorization compliance because it used a third party vendor and requires the programme to meet a national accreditation standard, so vendor accreditation transfers benefit and its absence transfers burden; establish which accreditations each vendor holds for the specific programme you are buying. Neither publishes pricing. Both should be asked what proportion of AI recommended denials are overturned on appeal, which is the number that reveals whether the model is calibrated or merely fast.